M
Manash K. Paul
Researcher at University of California, Los Angeles
Publications - 71
Citations - 1948
Manash K. Paul is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 17, co-authored 50 publications receiving 1192 citations. Previous affiliations of Manash K. Paul include University of California, Berkeley & Department of Biotechnology.
Papers
More filters
Journal ArticleDOI
Tyrosine kinase - Role and significance in Cancer
TL;DR: As angiogenesis is a major event in cancer growth and proliferation, tyrosine kinase inhibitors as a target for anti-angiogenesis can be aptly applied as a new mode of cancer therapy.
Journal ArticleDOI
Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling
Manash K. Paul,Bharti Bisht,Daphne O. Darmawan,Richard Chiou,Vi Luan Ha,William D. Wallace,Andrew T. Chon,Ahmed E. Hegab,Tristan Grogan,David Elashoff,Jackelyn A. Alva-Ornelas,Brigitte N. Gomperts +11 more
TL;DR: It is shown in mouse and human airway basal stem cells (ABSCs) that intracellular flux from low to moderate ROS levels is required for stem cell self-renewal and proliferation and redox-mediated regulation of lung stem cell function.
Journal ArticleDOI
Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling
Dan C. Wilkinson,Jackelyn A. Alva-Ornelas,Jennifer M.S. Sucre,Preethi Vijayaraj,Abdo Durra,Wade Richardson,Steven J. Jonas,Manash K. Paul,Saravanan Karumbayaram,Bruce Dunn,Brigitte N. Gomperts +10 more
TL;DR: This method for the generation of self‐assembled human lung tissue and its potential for disease modeling and drug discovery for lung diseases characterized by progressive and irreversible scarring such as idiopathic pulmonary fibrosis (IPF).
Journal ArticleDOI
Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
TL;DR: This present review provides a detailed overview of the recent progress in the theranostics application of nanoparticles including liposomes, polymeric, metal and bio-nanoparticles and summarizes the advantages and disadvantages of each approach considering the improvement for the lung cancer theranostic.
Journal ArticleDOI
6-Mercaptopurine and Daunorubicin Double Drug Liposomes—Preparation, Drug-Drug Interaction and Characterization
TL;DR: The dual incorporation of daunorubicin and 6-mercaptopurine in liposomes for better chemotherapy and thin layer chromatography and transmission electron microscopy results suggest stability of lipid andliposomes, thus pointing plausible existence of double drug liposome.